Acelyrin (NASDAQ: SLRN)
$4.68
(-4.1%)
-$0.20
Price as of May 10, 2024, 4:00 p.m. ET
Acelyrin Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Acelyrin Company Info
ACELYRIN, Inc. operates as a biopharma company. It engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company was founded by Shao-Lee Lin on July 27, 2020 and is headquartered in Agoura Hills, CA.
Valuation
Earnings Transcripts
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.